New
HealthMore in Health→
Tegoprubart Trial Signals Potential Alternative to Tacrolimus
Key Takeaways
- BESTOW compared tegoprubart with tacrolimus in first-time kidney-transplant recipients.
- Kidney function was higher with tegoprubart at each reported time point and significantly better at 18 months.
- The phase 2 findings will be presented at ASN Kidney Week 2026.
DE
DT Editorial Team··via medicalxpress.com